ORACLE
Chronicled blockchain prescription drug [shutterstock: 536140861, Syda Productions]
[shutterstock: 536140861, Syda Productions]
Blockchain Press Release

SAP And Chronicled Announce Blockchain Solution

SAP announced its latest partnership with Chronicled, a software company, to provide blockchain technology to help pharmaceutical companies comply with the U.S. Drug Supply Chain Security Act (DSCSA).

In this partnership, Chronicled’s MediLedger solution will serve as an integral part of SAP Information Collaboration Hub for Life Sciences, helping ensure patient safety and security for SAP’s customers in the pharmaceutical supply chain. Furthermore, it aims to help customer comply with the U.S. Drug Supply Chain Security Act (DSCSA).

“At AmerisourceBergen Corporation, we’re working extensively to assure compliance in accordance with the DSCSA,” says Jeffery Denton, AmerisourceBergen. “Our partnership with SAP now includes Chronicled’s MediLedger solution. They are consequently providing the best possible solution for our business. We utilize the unique benefits of both solutions to ensure our customers are receiving only authentic prescriptions medicines.”

SAP Information Collaboration Hub for Life Sciences helps verify the authenticity of medicine packages returned to wholesale distributors from hospitals and pharmacies, which are then resold to customers as mandated by the DSCSA.

Fusion with Chronicled’s MediLedger

Chronicled’s MediLedger solution will serve as an integral part of the collaboration hub. It will ensure information exchange across a wide industry network. By utilizing blockchain technology, MediLedger provides a secure, reliable and distributed network to SAP customers to enable verification routing within the collaboration hub. This ability to detect potential counterfeit products improves patient safety.

“This partnership across stakeholders in the distribution chain is the first step toward DSCSA interoperability,” says Pablo Medina, Genentech associate director, Contract and Channel Management. “This will support the continuous access to safe medicines for our patients. Furthermore, it meets the DSCSA returned product verification requirements our trading partners must comply with. We look forward to continuing working toward an interoperable system that will further safeguard the supply chain.”

The combined solution is already in use at nine of the top 20 global pharmaceutical companies; and also two of the top three U.S. wholesaler distributors use it.

Source:
SAP

ad_banner

Push
Our Authors